Scripps Research scientists unveil promising new HIV vaccine strategy


A new candidate HIV vaccine surmounts technical hurdles that stymied previous vaccine efforts and stimulates a powerful anti-HIV antibody response in animal tests. The new vaccine strategy is based on the HIV envelope protein, a complex, shape-shifting molecule that has been notoriously difficult to produce in vaccines in a way that induces useful immunity to HIV.